517 related articles for article (PubMed ID: 18809213)
1. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
[TBL] [Abstract][Full Text] [Related]
2. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
3. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
4. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
5. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
6. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
[TBL] [Abstract][Full Text] [Related]
7. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Motomura M; Iwanaga H
Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
[TBL] [Abstract][Full Text] [Related]
8. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
9. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
11. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
12. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
13. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
14. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
15. [Response to immunoadsorption and steroid therapies in a patient with carcinomatous Lambert-Eaton myasthenia syndrome accompanied by disturbed consciousness].
Ishikawa S; Takei Y; Tokunaga S; Motomura M; Nakao Y; Hanyu N
Rinsho Shinkeigaku; 2000 May; 40(5):459-63. PubMed ID: 11002728
[TBL] [Abstract][Full Text] [Related]
16. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; De Haro L; Seagar M
J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
[TBL] [Abstract][Full Text] [Related]
17. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
Takamori M; Iwasa K; Komai K
Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
[TBL] [Abstract][Full Text] [Related]
19. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer.
Monstad SE; Drivsholm L; Storstein A; Aarseth JH; Haugen M; Lang B; Vincent A; Vedeler CA
J Clin Oncol; 2004 Mar; 22(5):795-800. PubMed ID: 14990634
[TBL] [Abstract][Full Text] [Related]
20. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy.
Takamori M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
